Product Images Sildenafil Citrate

This is a description of a medication packaging for Sildenafil 20mg tablets. It includes dosage instructions, warnings, and information about the manufacturer and the product such as the NDC and production number.*

This appears to be a table displaying information related to drug interactions and dose adjustments. The table lists various drugs and their corresponding recommended dose adjustments based on the interacting drug fold change and 90% confidence interval. Additionally, there is a reference to the lack of benefit on exercise capacity when Sildenafil is added to bosentan therapy.*

This is a drug interaction table. The table includes Acenocoumarol and its interaction with other drugs such as aspirin, atorvastatin, bosentan, doxazosin, ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, Saquinavir, and Tolbutamide. Fold Change and 90% CI(Confidence Interval) Recommendations are given for some of these drugs. The table includes information on AUC (area under the curve), Cmax (maximum plasma concentration), INR (International Normalized Ratio), and BT (Bleeding Time). There is also a note about no benefit on exercise capacity when sildenafil is added to bosentan therapy. Furthermore, it is mentioned that co-administration of some drugs is not recommended based on the effect of ritonavir on sildenafil PK.*

This appears to be a table showing the change from baseline in meters for a study conducted over a period of 12 weeks. The study groups included a placebo group and groups taking sildenafil in doses of 20mg, 40mg, and 80mg TID (three times a day). The changes in distance walked for each group were measured at week 4, week 8, and week 12.*

This appears to be a graph displaying the mean change from baseline for different doses of the medication Sildenafil (1mg, 5mg TID, 20mg TID) at different time points (Week 4, Week 8, Week 12). The x-axis represents the week of the study, and the y-axis is labeled "Change from Baseline (meters)" with values ranging from 8 to 10. The graph also notes that the plot shows the mean change from baseline plus or minus the standard error for each treatment at each visit up to week 12.*